| Product Code: ETC320726 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The corticosteroid market in Malaysia is expected to grow steadily due to the increasing prevalence of skin disorders and various medical conditions that require corticosteroid treatments. These drugs are widely used in dermatology and can be found in creams, ointments, and other topical formulations. Expanding healthcare access and a growing awareness of skin health may contribute to the market`s positive outlook. However, regulatory changes and competition from alternative treatments may also impact the market dynamics.
The corticosteroid market in Malaysia is experiencing growth primarily due to an increasing prevalence of inflammatory and autoimmune diseases. Corticosteroids are widely prescribed for their anti-inflammatory and immunosuppressive properties. The aging population and rising healthcare awareness are contributing to the expansion of this market. However, regulatory changes and concerns about side effects may impact market dynamics in the future.
The Malaysia corticosteroid market faces challenges related to regulatory compliance, safety concerns, and competition from alternative treatments. Stringent regulatory requirements for pharmaceuticals can impact the approval and marketing of corticosteroid drugs. Additionally, concerns about side effects and long-term use can affect patient and physician preferences. Market players must navigate these regulatory hurdles and invest in research to address safety concerns while staying competitive in the pharmaceutical industry.
The corticosteroid market in Malaysia witnessed fluctuations during the COVID-19 pandemic. While corticosteroids played a crucial role in the treatment of severe cases, disruptions in the pharmaceutical supply chain affected availability. As the healthcare system stabilizes and the focus shifts towards long-term healthcare solutions, the corticosteroid market is expected to grow steadily, driven by both medical treatment and cosmetic applications.
The corticosteroid market in Malaysia is expected to expand with rising healthcare demands. Key players in this industry include GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., Novartis AG, and AstraZeneca plc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Corticosteroid Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Corticosteroid Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Corticosteroid Market - Industry Life Cycle |
3.4 Malaysia Corticosteroid Market - Porter's Five Forces |
3.5 Malaysia Corticosteroid Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Malaysia Corticosteroid Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.7 Malaysia Corticosteroid Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Malaysia Corticosteroid Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of skin disorders and autoimmune diseases in Malaysia |
4.2.2 Growing awareness about the benefits of corticosteroids in treating various medical conditions |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines governing the use of corticosteroids in Malaysia |
4.3.2 Presence of alternative treatment options and therapies for certain medical conditions |
5 Malaysia Corticosteroid Market Trends |
6 Malaysia Corticosteroid Market, By Types |
6.1 Malaysia Corticosteroid Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Corticosteroid Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Malaysia Corticosteroid Market Revenues & Volume, By Glucocorticoids, 2021-2031F |
6.1.4 Malaysia Corticosteroid Market Revenues & Volume, By Mineralocorticoids, 2021-2031F |
6.2 Malaysia Corticosteroid Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Corticosteroid Market Revenues & Volume, By Topical Steroids, 2021-2031F |
6.2.3 Malaysia Corticosteroid Market Revenues & Volume, By Inhaled Steroids, 2021-2031F |
6.2.4 Malaysia Corticosteroid Market Revenues & Volume, By Oral Forms, 2021-2031F |
6.2.5 Malaysia Corticosteroid Market Revenues & Volume, By Systemic Forms, 2021-2031F |
6.2.6 Malaysia Corticosteroid Market Revenues & Volume, By Others, 2021-2031F |
6.3 Malaysia Corticosteroid Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Corticosteroid Market Revenues & Volume, By Rheumatology Indications, 2021-2031F |
6.3.3 Malaysia Corticosteroid Market Revenues & Volume, By Skin Allergies, 2021-2031F |
6.3.4 Malaysia Corticosteroid Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.3.5 Malaysia Corticosteroid Market Revenues & Volume, By Gastroenterology, 2021-2031F |
6.3.6 Malaysia Corticosteroid Market Revenues & Volume, By Acute Respiratory Diseases, 2021-2031F |
6.3.7 Malaysia Corticosteroid Market Revenues & Volume, By Others, 2021-2031F |
7 Malaysia Corticosteroid Market Import-Export Trade Statistics |
7.1 Malaysia Corticosteroid Market Export to Major Countries |
7.2 Malaysia Corticosteroid Market Imports from Major Countries |
8 Malaysia Corticosteroid Market Key Performance Indicators |
8.1 Number of dermatologist visits prescribing corticosteroids |
8.2 Percentage of healthcare facilities offering corticosteroid treatments |
8.3 Patient satisfaction rates with corticosteroid therapies |
8.4 Research and development investments in new corticosteroid products |
8.5 Adoption rates of corticosteroids in different medical specialties |
9 Malaysia Corticosteroid Market - Opportunity Assessment |
9.1 Malaysia Corticosteroid Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Malaysia Corticosteroid Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.3 Malaysia Corticosteroid Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Malaysia Corticosteroid Market - Competitive Landscape |
10.1 Malaysia Corticosteroid Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Corticosteroid Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here